Look for:

Our offer for

MODERNA INC.


ISIN:
US60770K1079
WKN:
60770K107

2021/04/21 11:17:41
Price
131.52 EUR
Difference -0.35% (-0.46)

General attributes

ISINUS60770K1079
SymbolMRNA
ExchangeHamburg
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)52,149 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)132.42 EUR (425)
Ask (Ask size)132.62 EUR (425)
Open130.02 EUR
High131.88 EUR
Low129.98 EUR
Close (prev. day)131.98 EUR
VWAP-
Volume (pcs)307
Trading volume40,118.74
Number of trades5
Last size1

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Annual report: MODERNA INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Erste Group related products on underlying

Product type # products
Reverse convertibles 1

Recent research



2021/04/21 11:17:41
Price
131.52 EUR
Difference -0.35% (-0.46)

General attributes

ISINUS60770K1079
SymbolMRNA
ExchangeHamburg
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)52,149 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)132.42 EUR (425)
Ask (Ask size)132.62 EUR (425)
Open130.02 EUR
High131.88 EUR
Low129.98 EUR
Close (prev. day)131.98 EUR
VWAP-
Volume (pcs)307
Trading volume40,118.74
Number of trades5
Last size1

Performance and Risk

6M1Y3Y
Perf (%)+116.08%--
Perf (abs.)+70.90--
Beta0.640.710.28
Volatility81.6281.4681.46
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)134.07 EUR (403)
Ø price 30 days | Ø volume 30 days (pcs.)118.13 EUR (310)
Ø price 100 days | Ø volume 100 days (pcs.)119.01 EUR (902)
Ø price 250 days | Ø volume 250 days (pcs.)- EUR (627)
YTD High | date174.16 EUR (2021/01/29)
YTD Low | date86.51 EUR (2021/01/04)
52 Weeks High | date174.16 EUR (2021/01/29)
52 Weeks Low | date45.98 EUR (2020/05/27)

Erste Group related products on underlying

Product type # products
Reverse convertibles 1

All listings for MODERNA INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2021/04/2115:43132.70 EUR3.22390
Tradegate2021/04/2115:45132.30 EUR4.81285
Stuttgart2021/04/2115:15130.62 EUR0.2615
Nasdaq2021/04/2115:47159.15 USD182.9413,455
Munich2021/04/2113:00132.00 EUR0.015
London Stock Exchange European Trade Reporting2021/04/2109:04155.86 USD0.008
Hanover2021/04/2115:33133.76 EUR0.002
Hamburg2021/04/2111:17131.52 EUR0.045
Frankfurt2021/04/2115:43132.78 EUR0.4239
Duesseldorf2021/04/2115:29131.00 EUR0.0110
Berlin2021/04/2115:39132.90 EUR0.0110

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=144067&ID_TYPE_IMAGE_LOGO=2

Contact Details

MODERNA, INC.
- -
200 Technology Square - 02139 Cambridge
Telefon: 1-617-714-6500
Fax: 617-583-1998
E-mail: info@modernatx.com

PDF Downloads

Annual report: MODERNA INC.PDF Download

Company Profile

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Members of Management Board

Noubar AfeyanChairman of Board of Directors
Elizabeth NabelMember of Board of Directors
Francois NaderMember of Board of Directors
Robert LangerMember of Board of Directors
Sandra HorningMember of Board of Directors
Elizabeth TallettMember of Board of Directors
Paul SaganMember of Board of Directors
Stephen BerensonMember of Board of Directors
Stéphane BancelChairman of Managing Board
Charbel HaberMember of Executive Committee
Corinne Le GoffMember of Executive Committee
José VegaMember of Executive Committee
Melanie IvarssonMember of Executive Committee
Stephen HogeMember of Executive Committee
Tal ZaksMember of Executive Committee
David MelineMember of Executive Committee
Jacqueline MillerMember of Executive Committee
Jennifer LeeMember of Executive Committee
John LeporeMember of Executive Committee
Juan AndresMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.